Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts

  • Jon-Vidar Gaustad1Email author,
  • Trude G. Simonsen1,
  • Lise Mari K. Andersen1 and
  • Einar K. Rofstad1
BMC Cancer201717:411

https://doi.org/10.1186/s12885-017-3404-4

Received: 21 December 2016

Accepted: 7 June 2017

Published: 12 June 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
21 Dec 2016 Submitted Original manuscript
12 Mar 2017 Reviewed Reviewer Report - Yingyong Hou
17 Mar 2017 Reviewed Reviewer Report - Yongsong Guan
23 Mar 2017 Author responded Author comments - Jon-Vidar Gaustad
Resubmission - Version 2
23 Mar 2017 Submitted Manuscript version 2
3 Apr 2017 Reviewed Reviewer Report - Yingyong Hou
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Jun 2017 Editorially accepted
12 Jun 2017 Article published 10.1186/s12885-017-3404-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Group of Radiation Biology and Tumor Physiology, Department of Radiation Biology, Institute for Cancer Research

Advertisement